Aprepitant
Showing 26 - 50 of 207
Gastrointestinal Tumors, Chemo-induced Nausea and Vomiting Trial in Guangzhou (Aprepitant, Palonosetron, Dexamethasone)
Completed
- Gastrointestinal Neoplasms
- Chemotherapy-induced Nausea and Vomiting
- Aprepitant
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 3, 2020
Chemo-induced Nausea and Vomiting (CINV) Trial (Granisetron transdermal patch, Palonosetron, Aprepitant)
Not yet recruiting
- Chemotherapy-induced Nausea and Vomiting (CINV)
- Granisetron transdermal patch
- +4 more
- (no location specified)
Jun 2, 2021
Colorectal Cancer Trial in Japan (Aprepitant / Fosaprepitant)
Completed
- Colorectal Cancer
- Aprepitant / Fosaprepitant
-
Amagasaki, Hyogo, Japan
- +26 more
Feb 25, 2021
Cocaine Dependence, Alcohol Dependence Trial in Philadelphia (Placebo session 1, Aprepitant session 2, Placebo session 1,
Completed
- Cocaine Dependence
- Alcohol Dependence
- Placebo session 1, Aprepitant session 2
- Placebo session 1, Placebo session 2
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania, Treatment Research Center
Jul 1, 2020
Glioblastoma Trial in Ulm (Temozolomide, Aprepitant, Minocycline)
Completed
- Glioblastoma
- Temozolomide
- +9 more
-
Ulm, Baden-Württemberg, GermanyUniversity of Ulm School of Medicine
Oct 4, 2021
Anti-emetic Drug Upon Combination Chemotherapy for Non-small
Completed
- Non-small Cell Lung Cancer
- Aprepitant
-
Otsu, Shiga, JapanShiga University of Medical Science Hospital
Aug 28, 2020
Chemo-induced Nausea and Vomiting Trial in Greenfield Park (Zyprexa® (OLANZapine 5MG), Emend® (Aprepitant))
Completed
- Chemotherapy-induced Nausea and Vomiting
- Zyprexa® (OLANZapine 5MG)
- Emend® (Aprepitant)
-
Greenfield Park, Quebec, CanadaHôpital Charles-LeMoyne
Aug 17, 2020
Vomiting, Nausea Post Chemo, Head Neck Cancer Trial in Beijing (Aprepitant)
Completed
- Vomiting
- +2 more
- Aprepitant
-
Beijing, ChinaNational Cancer Center/ Cancer Hospital, Chinese Academy of Medc
Jul 14, 2020
Carcinoma, Non-small Cell Lung Trial in Changsha (Aprepitant, )
Completed
- Carcinoma, Non-small Cell Lung
- Aprepitant
- placebo
-
Changsha, Hunan, ChinaHunan Cancer hospital
Mar 25, 2020
Nausea and Vomiting, Postoperative Trial in Cairo (Aprepitant and Dexamethasone, Mirtazapine and Dexamethasone, Dexamethasone)
Completed
- Nausea and Vomiting, Postoperative
- Aprepitant and Dexamethasone
- +2 more
-
Cairo, EgyptAin-Shams University Hospitals
Dec 31, 2019
Nausea, Vomiting Trial in Toronto (Aprepitant, Palliative radiation therapy, Granisetron)
Terminated
- Nausea
- Vomiting
- Aprepitant
- +2 more
-
Toronto, Ontario, CanadaOdette Cancer Centre, Sunnybrook Health Sciences Centre
Sep 27, 2019
Pruritus Trial in Leuven (Desloratadine 5 mg, Aprepitant 125 mg, Ketotifen 1 MG)
Completed
- Pruritus
- Desloratadine 5 mg
- +2 more
-
Leuven, BelgiumCenter for Clinical Pharmacology
May 25, 2020
Healthy Trial in Nottingham (Aprepitant 125 mg)
Completed
- Healthy
- Aprepitant 125 mg
-
Nottingham, United KingdomQuotient Sciences Limited
Feb 24, 2020
Chemo-induced Nausea and Vomiting Trial in Chapel Hill (Olanzapine 5 MG, Placebo)
Completed
- Chemotherapy-induced Nausea and Vomiting
- Olanzapine 5 MG
- Placebo
-
Chapel Hill, North CarolinaUNC Hospital
Nov 28, 2022
Squamous Cell Carcinoma of Head and Neck, Chemo Induced Nausea and Vomiting Trial (nurse-led standardized intervention)
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- Chemotherapy Induced Nausea and Vomiting
- nurse-led standardized intervention
- (no location specified)
Mar 29, 2023
Olanzapine, CINV, Testicular Cancer by AJCC V6 and V7 Stage Trial in Guangzhou (Olanzapine Tablets, Placebo)
Recruiting
- Olanzapine
- +3 more
- Olanzapine Tablets
- Placebo
-
Guangzhou, Guangdong, ChinaSun Yat-sen University
Feb 14, 2022
Antiemetic for Highly Emetogenic Chemo Trial in Bangkok (aprepitant, olanzapine 10 mg, olanzapine 5 mg)
Unknown status
- Antiemetic for Highly Emetogenic Chemotherapy
- aprepitant
- +2 more
-
Bangkok, Thailand
- +1 more
Mar 14, 2019
C.Surgical Procedure; Gastrointestinal Trial in Guangzhou (palonosteron, dexamethasone, and fosaprepitant dissolved in 0.9%
Completed
- C.Surgical Procedure; Gastrointestinal
- palonosetron, dexamethasone, and fosaprepitant dissolved in 0.9% NaCl
- palonosetron, dexamethasone, and 0.9% NaCl
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated Hospital of Sun Yat-sen University
Dec 26, 2022
Gastroparesis Trial in United States (Aprepitant, Placebo)
Completed
- Gastroparesis
- Aprepitant
- Placebo
-
San Francisco, California
- +7 more
Apr 15, 2019
Squamous Cell Carcinoma of Head and Neck Trial (Combination 5-azacytidine and nivolumab, 5-azacytidine, Nivolumab)
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- Combination 5-azacytidine and nivolumab
- +2 more
- (no location specified)
Dec 7, 2022
Nausea, Vomiting Trial in Chicago (Aprepitant, Olanzapine, Aprepitant plus Olanzapine)
Unknown status
- Nausea
- Vomiting
- Aprepitant
- +2 more
-
Chicago, IllinoisRush University Medical Center
Jan 24, 2019
Tumors Trial in Xi'an (Fosaprepitant Dimeglumine for Injection)
Recruiting
- Neoplasms
- Fosaprepitant Dimeglumine for Injection
-
Xi'an, Shaanxi, ChinaThe First Affiliated Hospital of Air Force Military Medical Univ
Feb 22, 2023
Cervical Cancer, Nasopharyngeal Cancer, Chemo-induced Nausea and Vomiting Trial in Shantou (Fosaprepitant, tropisetron,
Recruiting
- Cervical Cancer
- +4 more
- Fosaprepitant
- +2 more
-
Shantou, Guangdong, ChinaCancer Hospital of Shantou University Medical College
Sep 29, 2022
Chemo Induced Nausea and Vomiting Pediatric Cancer Patients Trial in Shanghai (Fosaprepitant, Placebo(normal saline))
Not yet recruiting
- Chemotherapy Induced Nausea and Vomiting Pediatric Cancer Patients
- Fosaprepitant
- Placebo(normal saline)
-
Shanghai, ChinaShanghai Children's Medical Center
Jan 28, 2022